Attach to Form 990 or Form 990-EZ.
Go to
www.irs.gov/Form990 for instructions and the latest information.
| (i) Name of supported organization | (ii) EIN | (iii) Type of organization (described on lines 1- 10 above (see instructions)) | (iv) Is the organization listed in your governing document? | (v) Amount of monetary support (see instructions) | (vi) Amount of other support (see instructions) | |
|---|---|---|---|---|---|---|
| Yes | No | |||||
|
Total |
||||||
Calendar year
(or fiscal year beginning in)
![]() |
(a) 2019 | (b) 2020 | (c) 2021 | (d) 2022 | (e) 2023 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grant.") .. | 108,955,331 | 88,149,776 | 113,184,567 | 93,952,438 | 109,713,896 | 513,956,008 |
| 2 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf .... | ||||||
| 3 | The value of services or facilities furnished by a governmental unit to the organization without charge.. | ||||||
| 4 | Total. Add lines 1 through 3 | 108,955,331 | 88,149,776 | 113,184,567 | 93,952,438 | 109,713,896 | 513,956,008 |
| 5 | The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f) .. | ||||||
| 6 | Public support. Subtract line 5 from line 4. | 513,956,008 | |||||
Calendar year
(or fiscal year beginning in)
![]() |
(a) 2019 | (b) 2020 | (c) 2021 | (d) 2022 | (e) 2023 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 7 | Amounts from line 4.. | 108,955,331 | 88,149,776 | 113,184,567 | 93,952,438 | 109,713,896 | 513,956,008 |
| 8 | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources... | 3,352,336 | 2,566,585 | 3,236,138 | 3,502,605 | 5,589,273 | 18,246,937 |
| 9 | Net income from unrelated business activities, whether or not the business is regularly carried on.. | ||||||
| 10 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.).. | ||||||
| 11 | Total support. Add lines 7 through 10 | 532,202,945 | |||||
Calendar year (or fiscal
year beginning in) ![]() |
(a) 2019 | (b) 2020 | (c) 2021 | (d) 2022 | (e) 2023 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") . | ||||||
| 2 | Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose | ||||||
| 3 | Gross receipts from activities that are not an unrelated trade or business under section 513 ..... | ||||||
| 4 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf... | ||||||
| 5 | The value of services or facilities furnished by a governmental unit to the organization without charge | ||||||
| 6 | Total. Add lines 1 through 5 | ||||||
| 7a | Amounts included on lines 1, 2, and 3 received from disqualified persons | ||||||
| b | Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year. | ||||||
| c | Add lines 7a and 7b.. | ||||||
| 8 | Public support. (Subtract line 7c from line 6.) | ||||||
Calendar year
(or fiscal year beginning in)
![]() |
(a) 2019 | (b) 2020 | (c) 2021 | (d) 2022 | (e) 2023 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 9 | Amounts from line 6... | ||||||
| 10a | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources.. | ||||||
| b | Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975. | ||||||
| c | Add lines 10a and 10b. | ||||||
| 11 | Net income from unrelated business activities not included on line 10b, whether or not the business is regularly carried on. | ||||||
| 12 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.) .. | ||||||
| 13 | Total support. (Add lines 9, 10c, 11, and 12.).. | ||||||
| Section A - Adjusted Net Income | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Net short-term capital gain | 1 | ||||
| 2 | Recoveries of prior-year distributions | 2 | ||||
| 3 | Other gross income (see instructions) | 3 | ||||
| 4 | Add lines 1 through 3 | 4 | ||||
| 5 | Depreciation and depletion | 5 | ||||
| 6 | Portion of operating expenses paid or incurred for production or collection of gross income or for management, conservation, or maintenance of property held for production of income (see instructions) | 6 | ||||
| 7 | Other expenses (see instructions) | 7 | ||||
| 8 | Adjusted Net Income (subtract lines 5, 6 and 7 from line 4) | 8 | ||||
| Section B - Minimum Asset Amount | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Aggregate fair market value of all non-exempt-use assets (see instructions for short tax year or assets held for part of year): | 1 | ||||
| a | Average monthly value of securities | 1a | ||||
| b | Average monthly cash balances | 1b | ||||
| c | Fair market value of other non-exempt-use assets | 1c | ||||
| d | Total (add lines 1a, 1b, and 1c) | 1d | ||||
| e |
Discount claimed for blockage or other factors (explain in detail in Part VI): |
|||||
| 2 | Acquisition indebtedness applicable to non-exempt use assets | 2 | ||||
| 3 | Subtract line 2 from line 1d | 3 | ||||
| 4 | Cash deemed held for exempt use. Enter 0.015 of line 3 (for greater amount, see instructions). | 4 | ||||
| 5 | Net value of non-exempt-use assets (subtract line 4 from line 3) | 5 | ||||
| 6 | Multiply line 5 by 0.035 | 6 | ||||
| 7 | Recoveries of prior-year distributions | 7 | ||||
| 8 | Minimum Asset Amount (add line 7 to line 6) | 8 | ||||
| Section C - Distributable Amount | Current Year | |||||
| 1 | Adjusted net income for prior year (from Section A, line 8, Column A) | 1 | ||||
| 2 | Enter 85% of line 1 | 2 | ||||
| 3 | Minimum asset amount for prior year (from Section B, line 8, Column A) | 3 | ||||
| 4 | Enter greater of line 2 or line 3 | 4 | ||||
| 5 | Income tax imposed in prior year | 5 | ||||
| 6 | Distributable Amount. Subtract line 5 from line 4, unless subject to emergency temporary reduction (see instructions) | 6 | ||||
| Section D - Distributions | Current Year | |
|---|---|---|
| 1 Amounts paid to supported organizations to accomplish exempt purposes | 1 | |
|
2
Amounts paid to perform activity that directly furthers exempt purposes of supported organizations, in excess of income from activity |
2 | |
| 3 Administrative expenses paid to accomplish exempt purposes of supported organizations | 3 | |
| 4 Amounts paid to acquire exempt-use assets | 4 | |
| 5 Qualified set-aside amounts (prior IRS approval required - provide details in Part VI) | 5 | |
| 6 Other distributions (describe in Part VI). See instructions | 6 | |
| 7Total annual distributions. Add lines 1 through 6. | 7 | |
|
8
Distributions to attentive supported organizations to which the organization is responsive (provide details in Part VI). See instructions |
8 | |
| 9 Distributable amount for 2023 from Section C, line 6 | 9 | |
| 10 Line 8 amount divided by Line 9 amount | 10 | |
| Section E - Distribution Allocations (see instructions) |
(i) Excess Distributions |
(ii) Underdistributions Pre-2023 |
(iii) Distributable Amount for 2023 |
|
|---|---|---|---|---|
| 1 Distributable amount for 2023 from Section C, line 6 | ||||
|
2
Underdistributions, if any, for years prior to 2023 (reasonable cause required-- explain in Part VI).
See instructions. |
||||
| 3 Excess distributions carryover, if any, to 2023: | ||||
| a From 2018....... | ||||
| b From 2019....... | ||||
| c From 2020....... | ||||
| d From 2021....... | ||||
| e From 2022....... | ||||
| fTotal of lines 3a through e | ||||
| g Applied to underdistributions of prior years | ||||
| h Applied to 2023 distributable amount | ||||
|
i
Carryover from 2018 not applied (see instructions) |
||||
| j Remainder. Subtract lines 3g, 3h, and 3i from line 3f. | ||||
| 4Distributions for 2023 from Section D, line 7: | ||||
| $ | ||||
| a Applied to underdistributions of prior years | ||||
| b Applied to 2023 distributable amount | ||||
| c Remainder. Subtract lines 4a and 4b from line 4. | ||||
|
5
Remaining underdistributions for years prior to 2023, if any. Subtract lines 3g and 4a from line 2. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
6
Remaining underdistributions for 2023. Subtract lines 3h and 4b from line 1. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
7 Excess distributions carryover to 2024. Add lines 3j and 4c. |
||||
| 8 Breakdown of line 7: | ||||
| a Excess from 2019..... | ||||
| b Excess from 2020..... | ||||
| c Excess from 2021..... | ||||
| d Excess from 2022..... | ||||
| e Excess from 2023..... | ||||
| Facts And Circumstances Test |
|---|
| Return Reference | Explanation |
|---|
| Software ID: | 23017659 |
| Software Version: | 23.1.0.0 |
| Return Reference | Explanation |
|---|---|
| Form 990, Part III, Line 4 | We Fight to End Diabetes |
| Form 990, Part III, Line 4 | The mission of the American Diabetes Association ADA, founded in 1940, is to prevent and cure diabetes and to improve the lives of all people affected by diabetes. This chronic disease is one of the fastest growing in the world, with 136 million Americans living with diabetes or prediabetes and a new diagnosis occurring every 26 seconds. |
| Form 990, Part III, Line 4 | In the face of this epidemic, our mission has never been clearer, and our vision of a life free of diabetes and all its burdens is more critical than ever before. Through advocacy, program development, and education, we aim to improve the quality of life for everyone affected by diabetes. |
| Form 990, Part III, Line 4 | The moving force behind the work of the ADA is a network of more than 565,000 volunteers, their families and caregivers, a professional society of nearly 12,000 health care professionals, as well as nearly 350 staff members. |
| Form 990, Part III, Line 4 | At the ADA, weve always been fighters. We have the knowledge, the tools, and the will to bend the curve and slow the growth of diabetes while improving care and seeking a cure. We will do everything to fight this disease and everyone who stands with us helps America fight back with even greater strength. |
| Form 990, Part III, Line 4 | Thats the promise of our new brand campaign, We Fight, unveiled in September 2023. We Fight calls urgent attention to the fact that too many people are being diagnosed with diabetes, too many people are suffering the health consequences of diabetes, and too many others are not paying attention to diabetes. It asks Americans to make a stand, uplift our loved ones and communities, and join the ADA to help those living with diabetes and in the fight of our lives to end diabetes. |
| Form 990, Part III, Line 4 | The campaign was also the cornerstone for American Diabetes Month. With support from CVS Health, the campaign created positive disruption and fueled conversations about diabetes in places where Americans shop, scroll, listen, and watch. The We Fight campaign was activated across a variety of channels, including Times Square, and Higi stations in pharmacies and grocery stores, where consumers can learn their risk for and monitor diabetes and other health conditions. The campaign also reached audiences across cable TV, streaming platforms and social media. |
| Form 990, Part III, Line 4 | We Fight Through Research. For decades, the ADA has played a pivotal role as a direct funder, driver, and shaper of diabetes research that improves and saves lives. Because of our longstanding research program and strategic collaborations, diabetes is a condition we know we can treat and often prevent. But while we have learned much about diabetes, there is much left to discover. The ADA provides critical funding to support innovative scientific discovery that translates into better treatment and healthier lives and advances the possibility of a cure. And because the diabetes epidemic is too large to tackle alone, we partner with governmental agencies and fellow nonprofit organizations to expand our reach and cultivate the most creative and fruitful solutions. |
| Form 990, Part III, Line 4 | Investing in the Brightest Minds. Since 1952, the ADA has awarded more than 955 million to researchers at leading institutions across the United States. Our research portfolio includes 171 active awards, including 52 new projects funded this year. The ADAs laser-focused research strategy helps us respond to the evolving diabetes landscape and invest in specific areas that are most relevant for people affected by diabetes. For 2023, that meant investing in Improving the Lives of Women with Diabetes Across the Lifespan, Tackling the Epidemic of Youth Onset Type 2 Diabetes, Supporting the Psychological and Emotional Needs of People with Diabetes. We complement these targeted research grants with our early-career scholars program and postdoctoral fellowships. Supporting young, talented investigators is essential for innovation and ensuring a robust pipeline of diabetes researchers for years to come. |
| Form 990, Part III, Line 4 | Pathway to Progress. The Pathway to Stop Diabetes Pathway program was founded with a singular vision To introduce a new generation of brilliant scientists to diabetes research. The ADA supports Pathway scientists for five to seven years, giving them the freedom to explore new ideas without the constraints of traditional project based funding. Over the past decade, this initiative has successfully propelled 39 scientists into independent faculty positions, resulting in numerous inventions, patents, startups, and published manuscripts, showcasing its transformative impact on diabetes care. In 2023, we welcomed three new Pathway scientists Chelsea Hepler, PhD, Northwestern University. Dr. Hepler will research the complex relationship between the circadian clock and the inflammation of adipose tissue fat cells present in people with obesity, and its ensuing impact on metabolism. Debora Rodrigues Sobreira, PhD, The Regents of the University of California, Los Angeles. Dr. Sobrieras work will use advanced methodologies such as data science, disease modeling, and genetic screening to better understand how genetic signals lead to the onset of type 2 diabetes. Lu Wang, PhD, Tufts University. Dr. Wang will investigate whether healthy shopping nudges and financial incentives delivered in an online retail setting can promote healthier food choices, support diabetes management, and improve health equity among low income communities |
| Form 990, Part III, Line 4 | Making Diabetes a National Priority. ADA lobbying helped secure robust funding in the federal FY24 Omnibus Appropriations bill for key diabetes research and prevention programs Centers for Disease Control and Prevention CDC Division of Diabetes Translation 156,129,000, National Institutes of Health NIH National Institute of Diabetes and Digestive and Kidney Diseases NIDDK 2,310,271,000, National Diabetes Prevention Program National DPP 37,300,000, Advanced Research Projects Agency for Health 1,500,000,000. Diabetes Advocates also helped secure a 10 million increase for the Special Diabetes Program SDP and the Special Diabetes Program for Indians, which is authorized through December 31, 2024, at an annual rate of approximately 160 million per year. This is the first funding increase for SDP in 20 years. |
| Form 990, Part III, Line 4 | Scientific Sessions. In June, the ADA hosted the 83rd Scientific Sessions, the worlds premier meeting for diabetes professionals in San Diego, CA. This year we offered shorter, more targeted sessions that garnered more interaction among participants in person and virtually. The Scientific Sessions shared the latest findings in diabetes research, prevention, and care through 521 live presentations, 216 educational sessions, 2,077 abstracts published, Over 11,000 attendees. The Scientific Sessions was also the setting for the ADAs first ever Innovation Challenge, a live pitch competition spotlighting novel business concepts for diabetes care before a panel of potential funders Helmsley Charitable Trust, Swiss Diabetes Venture Fund, and Startup Health. Applicants were whittled down to three winners GO Pen GO Pen will be the only insulin pen where people with diabetes can buy insulin in vials and fill their own pen reservoirs. Minutia Development of the first functional cure that can be given broadly for type 1 diabetes through subcutaneous transplants of immune evasive insulin producing cells managed in real time by proprietary cell based sensors. Oregon Health Sciences University Distal and proximal interventions that occur across all systems including health care, social services, homes neighborhoods, schools, employers, and communities all to improve diabetes outcomes. |
| Form 990, Part III, Line 4 | Health equity spotlight Research. In November, we gathered nine ADA funded researchers for the Innovative Nutrition and Lifestyle Strategies for Diabetes Prevention and Care in Underserved Communities Workshop at our headquarters in Arlington, VA. The workshop featured a range of projects seeking to improve outcomes for people who are at higher risk for diabetes through culturally relevant and linguistically responsive interventions, from diabetes nutrition education for American Indian Alaska Natives, to exercise programs for Black people, to obesity prevention among Hispanic Latino infants and toddlers. |
| Form 990, Part III, Line 4 | We Fight Through Quality of Care. Despite continued advances in therapies and technology, health outcomes for people with diabetes have not improved significantly. Too many people are still developing prediabetes and diabetes, and too few are achieving a target A1C under 7 percent. This cant go on. The ADA is taking immediate action by driving broad adoption of our revered Standards of Care in Diabetes Standards of Care especially in primary care where 90 percent of diabetes care takes place. Our educational programs, publications, and initiatives put comprehensive, evidence based guidelines into the hands of health care professionals so they can provide the best possible care to the diabetes community. |
| Form 990, Part III, Line 4 | 2024 Standards of Care. For more than three decades, the ADA has set the benchmark in diabetes care through its Standards of Care publication. This essential resource offers guidance on the comprehensive strategies for the management of type 1 diabetes, type 2 diabetes, gestational diabetes GDM, and prediabetes, drawing on the most recent scientific findings and clinical trials. The latest edition, released in December 2023, features Cutting edge recommendations for Managing obesity, Screening for cardiovascular disease, Evaluating and treating bone health, Disability with diabetes, Preventing hypoglycemia. New information on The possible association between COVID19 infections and diabetes, Diabetes screening, Delaying type 1 diabetes onset. The Standards of Care also continues to emphasize inclusion, cultural sensitivity, and person-centered care. |
| Form 990, Part III, Line 4 | Introducing the Institute of Learning. Health care professionals have a new destination for enhancing diabetes knowledge, the ADAs Institute of Learning. The state of the art education portal houses more than 70 free continuing education CE courses, webinars, self assessments, and more to support them in providing the highest level of care. The Institute of Learning aggregates content from key ADA strategic initiatives, including Diabetes Is Primary, Focus on Diabetes, Making Diabetes Technology Work, Overcoming Therapeutic Inertia, Safe at School, Time in Range, and Womens Health. By the end of the year, more than 28,000 professionals had signed on. |
| Form 990, Part III, Line 4 | Primary Care Council. The ADAs Primary Care Council improves the adoption of our Standards of Care among primary care professionals PCPs who are on the front lines of diabetes care. The council is a coordinated effort with seven other leading primary care organizations American Academy of Family Physicians AAFP, American Academy of Physician Associates AAPA, American Association of Nurse Practitioners AANP, American College of Osteopathic Family Physicians ACOFP, American College of Physicians ACP, American Pharmacists Association APhA, American Society of Health System Pharmacists ASHP. In its first full year, the Primary Care Council reached thousands of PCPs through educational materials, webinars, and conferences with a focus on encouraging providers to intensify therapies or try new ones when a person has trouble meeting their blood glucose blood sugar goals. |
| Form 990, Part III, Line 4 | Diabetes Self Management Education and Support DSMES. Since 1986, the ADAs Education Recognition Program ERP has been responsible for evaluating and recognizing DSMES services across the United States. In 2023, new applications increased by 43 percent and accepted applications by 19 percent, indicating a welcome expansion of high quality DSMES for Americans with diabetes. Our team also helps ERP programs stay abreast of the National Standards for DSMES and the ADAs Standards of Care. We launched the first on demand ERP DSMES Standards Medicare Reimbursement Symposium via the ADAs Institute of Learning to help health care professionals learn more about DSMES billing and reimbursement. |
| Form 990, Part III, Line 4 | Empowering Community Health Workers. In 2023, the ADA continued to support and promote community health workers CHWs as part of the diabetes care team. CHWs play an increasingly vital role in the public health landscape by enhancing the traditional health care workforce and making inroads into underserved communities helping to create community to clinic linkages for people with diabetes. With funding support from Bank of America, the ADA developed its first fully Spanish language CE course for CHWs, with 90 percent of learners reporting high and very high levels of satisfaction. |
| Form 990, Part III, Line 4 | Type 1 Diabetes Screening Awareness. The past decade has brought about remarkable advances in how we detect type 1 diabetes and define diagnosis. Now its time to put those changes into widespread practice. With support from Sanofi, the ADA has embarked on a groundbreaking initiative to dissect the challenges and opportunities for implementing type 1 diabetes screening and spreading awareness. We convened a dynamic roundtable of 20 leading experts to delve into the latest scientific developments, explore potential educational resources, and craft impactful messages for health care professionals, people living with type 1, and their families. Our proactive approach signifies an important step forward in enhancing early detection helping more people avoid dangerous diabetic ketoacidosis DKA at diagnosis while giving them the best chance at a long, healthy life with type 1. |
| Form 990, Part III, Line 4 | Minding Mental Health. The stresses of managing diabetes 24 7 can leave people more prone to distress, burnout, and depression and yet, mental health remains an overlooked topic in diabetes care. This needs to change. Thats why the ADA is working to integrate behavioral health care into diabetes management and is arming mental health professionals with a better understanding of life with diabetes. Our mental health programming reached over 68,000 health care professionals this year, more than a 250 percent increase over 2022. We also added 54 professionals to the searchable Mental Health Provider Directory for a total of 323 licensed practitioners with expertise in diabetes care. And with support from the Leona M. and Harry B. Helmsley Charitable Trust, in 2023 we introduced two critically important mental health programs Diabetes Education 101 for the Behavioral Health Professional helps participants deliver a more comprehensive and empathetic level of care to people with diabetes. Exploring Mental Health and Diabetes Through Case Studies dives into 12 compelling, real life cases representing a spectrum of cultural backgrounds and social determinants of health. |
| Form 990, Part III, Line 4 | Journals Podcasts. The ADAs trusted publications distill the latest research and best practices so health care professionals can provide the best level of care to people with and at risk for diabetes. Highlights in 2023 included Our scientific and medical journals reached more than 35,000 health care professionals with cutting-edge research on the prevention and treatment of diabetes and its complications. ADA published studies were cited more than 157,000 times. Diabetes Care and Diabetes ranked second and fourth among the 145 journals in the field of endocrinology and metabolism, making them the top two journals publishing diabetes research. Since 2015, the Diabetes Core Update podcast has given busy professionals an accessible way to learn about the latest clinical research published in ADA journals and beyond. This year we expanded our audio reach with a new suite of podcasts Diabetes Care On Air features interviews with authors of editorselected articles and highlights of research in Diabetes Care. DiabetesBio offers insightful interviews with authors of editor selected biomedical research articles published in Diabetes. Diabetes Day by Day delivers practical advice for people with diabetes and their caregivers on overcoming everyday challenges. |
| Form 990, Part III, Line 4 | Health equity spotlight Quality of Care. With support from Genentech, the ADA formed an eye health equity program to promote early detection and treatment among people of color who are more than twice as likely to develop significant visual complications from diabetes. The initiative kicked off with a community event in Birmingham, AL as we identified solutions for more equitable eye care, such as improving coordination among eye care specialists and members of the diabetes care team. To date, we have shared educational resources with over 2,000 health care professionals and conducted over 700 eye exams for some people, their very first. This collaboration gets us closer to preventing diabetes related eye disease and vision loss for the people of Birmingham, plus a model to follow for other hard hit communities across the Diabetes Belt and beyond. |
| Form 990, Part III, Line 4 | We Fight Through Food Nutrition. Healthy eating is essential for preventing prediabetes and type 2 diabetes and for managing all types of diabetes, yet one in five Americans with diabetes dont have regular access to nutritious food. The ADA is committed to driving resources and policy changes that help people choose and prepare healthy foods, navigate nutrition labels, overcome food insecurity, and more. |
| Form 990, Part III, Line 4 | What Can I Eat Program. In 2023, we partnered with the Elevance Health Foundation to deliver an enhanced version of the no cost What Can I Eat WCIE program to more than 2,600 people in underserved communities in Indiana, New York, Ohio, and Virginia. As WCIE continues to expand in person and virtually, well help more people with type 2 diabetes shop better, eat better, and live better while addressing the social determinants of health that contribute to the diabetes epidemic. |
| Form 990, Part III, Line 4 | Diabetes Food Hub. The ADAs Diabetes Food Hub continues to be a popular destination for people living with diabetes, their caregivers, and health care professionals looking for diabetes friendly recipes and meal plans, cooking tips, and more. Its user base grew in 2023, driven in large part by our expert content, monthly online cooking classes, and high social media engagement. |
| Form 990, Part III, Line 4 | Nourishing Health. In 2023 we joined the NourishMyHealthSM nutrition security and education initiative, led by the National Association of Chain Drug Stores in collaboration with the American Heart Association AHA, the American Cancer Society ACS, and the Food is Medicine Institute at the Friedman School of Nutrition Science and Policy at Tufts University. NourishMyHealth shares free resources to help consumers and health care professionals understand the connection between food and wellbeing and how eating more nutritious foods can help reduce the risk of diabetes, heart disease, and cancer. In its first year, the partnership reached 60,000 people through the pharmacy setting. |
| Form 990, Part III, Line 4 | Health equity spotlight Food Nutrition. In Chicagos South Side, over 500,000 people experience nutritious food insecurity. Diabetes looms large, as 20 percent of residents in some neighborhoods live with diabetes nearly twice the citys average. Against this backdrop, a partnership blossomed between the ADA and Dions Chicago Dream DCD, with vital support from Baxter. This collaboration provides weekly deliveries of fresh fruits and vegetables to South Side residents doorsteps along with diabetes education and diabetes friendly recipes. DCDs deliveries reached 1,000 households in 2023, impacting over 5,000 people and transforming this communitys narrative from one of food scarcity to food security. |
| Form 990, Part III, Line 4 | We Fight Through Health Equity Access. Diabetes is a striking representation of health disparities, as those living in under resourced communities are more likely to develop the disease and experience related complications. This is unacceptable. Everyone deserves equitable access to the best possible diabetes prevention, care, and treatment. Thats why addressing health equity is woven into everything the ADA does. Were removing obstacles for all people with and at risk for diabetes, enabling access to essential technology, affordable medication, healthy foods, and quality health care. We wont back down until everyone affected by diabetes has what they need to thrive. Until health equity is the standard in national health policy and in every providers office. Until people with diabetes can lead lives free from fear, discrimination, and stigma. |
| Form 990, Part III, Line 4 | Advocacy in Action. The ADAs state, federal, and legal advocacy is creating positive change for the diabetes community. Here are some of our wins from 2023. Insulin is dramatically more affordable In 2023, we saw tremendous progress in our quest to make insulin more affordable for the 8.4 million Americans who rely on it to survive. By the end of the year, half of U.S. states and DC and Medicare capped monthly out of pocket costs for this lifesaving medication. Additionally, the three leading insulin manufacturers limited costs for people with diabetes and ADA endorsed bills capping out of pocket costs to 35 for those on commercial health insurance plans were introduced in the U.S. Senate and House. Diabetes technology is more accessible Real time continuous blood glucose blood sugar monitoring has led to tremendous outcomes for people with diabetes who, without such a device, may have experienced potentially life threatening complications. However, research shows that those from under resourced communities consistently lack access to this technology. The ADA led efforts that resulted in greater access to continuous glucose monitors CGMs for people with diabetes enrolled in Medicare, Veterans Affairs benefits, and more than 10 state Medicaid programs including the most populous states in the U.S. |
| Form 990, Part III, Line 4 | Reducing Unnecessary Amputations. As many as 80 percent of non traumatic lower limb amputations happen due to diabetes complications. Amputations in the United States are also substantially more prevalent among people of color.During 2023, we helped ensure the federal Amputation Reduction and Compassion ARC Act was reintroduced. The legislation would require Medicare and Medicaid to fully cover screening tests for people who are at risk of peripheral artery disease PAD and promote education, testing, and treatment for PAD and other conditions that can lead to amputation. Additionally, this year the ADAs Amputation Prevention Alliance hosted its first Preventing Diabetes Related Amputations in America A Solutions Summit to highlight the challenges that have led to increases in diabetes related amputations and opportunities for action. |
| Form 990, Part III, Line 4 | Treating Obesity as a Disease. The ADA is calling on policymakers and the health care community to recognize and treat obesity as a disease and keep more people from developing other serious health conditions like type 2 diabetes and heart disease. This year we launched the Diabetes Prevention and Obesity Treatment Initiative to increase access to obesity treatment and services at the federal and state levels. Our robust efforts included partnering with groups that share our interests and goals, convening a summit for policymakers, participating in World Obesity Day March 4, supporting the Treat and Reduce Obesity Act TROA, and engaging in legislation in 12 states. |
| Form 990, Part III, Line 4 | The Staggering Costs of Diabetes. On November 1, the ADA published the Economic Costs of Diabetes in the U.S. in 2022 report, which put the nations annual cost of diabetes at 412.9 billion. People with diagnosed diabetes now account for one of every four health care dollars spent in the U.S. Whats more, direct medical costs attributed to diabetes, estimated at 306.6 billion, increased by 7 percent between 2017 and 2022. This comprehensive report, which the ADA publishes every five years, underscores diabetes enormous physical and financial burden on our country and is a call to action for policymakers and the entire health care system to prioritize affordable diabetes care, especially for vulnerable and underserved communities. |
| Form 990, Part III, Line 4 | Local Solutions, National Impact. The Collaboration for Equitable Health, powered by Bank of America, is a four-year initiative that brings together the ADA, the ACS, the AHA, and the University of Michigan School of Public Health to improve health outcomes in communities of color. This work leverages our collective resources and voices to change the trajectory of diabetes, heart disease, cancer, and stroke. In the collaborations first full year, we Brought core ADA programs such as Project Power to 28 community based organizations in five markets Washington, DC Denver, CO Albuquerque, NM Charlotte, NC and Atlanta, GA. Provided free training to more than 1,200 CHWs nationwide to increase their knowledge of diabetes management. Awarded grants to 90 grassroots organizations and health clinics, fueling culturally relevant interventions that directly address the health challenges of these communities. Delivered advocacy training to empower people to advocate for policies that improve health withing their communities. |
| Form 990, Part III, Line 4 | Technology access. The prevalence of adult diabetes exceeds 20 percent in parts of Franklin County, OH. Here, diabetes is compounded by hardship more than half of residents live below 200 percent of the federal poverty line and the life expectancy average is 65 years. Such socioeconomic barriers often put the latest diabetes technology and comprehensive DSMES out of reach for the people who need it most. In partnership with Abbott and the National Center for Urban Solutions NCUS, the ADA piloted the U Got This program, providing CGMs and six months of wraparound wellness coaching to 116 people with diabetes, many of them receiving Medicaid. Thanks to continuous blood glucose monitoring and healthy habits, participants reported significant improvements in their A1C and a tangible shift in their overall quality of life. |
| Form 990, Part III, Line 4 | ADA in the Community. Whether youre battling diabetes or have a loved one who is, building connections with other people can be the best medicine. The ADAs community programs offer equal parts education and inspiration so people of all ages can feel supported. |
| Form 990, Part III, Line 4 | Embracing the Spirit of Camp. ADA Camp complete with swimming, singing, skills-building, and making lifelong friendships is a rite of passage every child with diabetes should experience. At ADA Camp, thousands of children living with diabetes get to enjoy this quintessential experience in a supportive, medically safe environment. Our day camps, overnight camps, and family retreats are a lifeline for children with diabetes to develop the critical skills they need to thrive. This year, more than 2,700 campers joined us for 33 camp sessions nationwide. ADA Camp is powered by more than 1,500 volunteers, 600 trained medical staff, and more than 400,000 in annual need-based financial aid. |
| Form 990, Part III, Line 4 | Project Power for All. Youre never too young or old to adopt healthy habits. The ADAs Project Power empowers adults and children to reduce their risk for or manage and thrive with type 2 diabetes. Project Power for youth aims to slow the trajectory of childhood obesity and its consequences among youth ages 5 to 12. The fun, no cost in person program promotes making healthy food choices, increasing physical activity, and building family and peer support. More than 9,000 children participated across 37 states and Washington, DC in 2023. Project Power for adults is a 12 month no cost lifestyle change program that raises diabetes awareness and offers diabetes risk reduction education to people who are at risk for type 2 diabetes or have prediabetes, and healthy living strategies for people with type 2 diabetes. The program combines interactive lessons with a health coach, small support groups, and tools and resources to help participants reach their personal health goals. This year, we focused on engaging more adults in high risk communities. Over 6,000 adults registered for Project Power with 4,309 participants entering a cohort in 2023 and more to start in 2024 across all 50 states and DC. Also, more than 17,000 people completed the ADAs Type 2 Diabetes Risk Test thanks to our Project Power marketing campaigns. |
| Form 990, Part III, Line 4 | Special Events. The ADAs signature events bring together walkers, riders, and donors to raise critical funds for our life changing programs and uplift all people living with diabetes. When were united by a sense of shared purpose, we can do even more to achieve our ultimate goal ending diabetes once and for all.Were grateful to our supporters who collectively raised a total of 12 million through 14 Tour de Cure events 6,000 riders, 8 Step Out Walk to Stop Diabetes events 4,000 walkers, 19 State of Diabetes events, 10 signature events, 208 do it yourself events |
| Form 990, Part III, Line 4 | Other Program Services revenue reported in Line 4d 1,725,045 relates to the investment in real estate. This investment represents a 1998 donor bequest that restricted the ADA from selling the property for 25 years. A portion of the property is leased to corporations and derives monthly income that is reported in investment income. |
| Form 990, Part VI, Section A, Line 6,7a | The American Diabetes Association has established the voting membership of the ADA as the Voting Members. The Voting Members are comprised of all of the members of the Board of Directors and additional delegates. The Voting Members vote on the election of the organizations governing body each year. No governance decisions are reserved to or subject to approval by the membership. |
| Form 990, Part VI, Section B, Line 11 | IRS Review Process by the Governing Body The American Diabetes Association Board of Directors assigns the Audit and Governance Committee the oversight responsibility of the IRS Form 990 and its supplemental schedules prior to completion. After review by management and BDO, the final signed 990 was provided to the ADAs Board of Directors prior to filing with the IRS. |
| Form 990, Part VI, Section B, Line 12 | Managing Conflict of Interest To identify potential conflicts of interest with appropriate due diligence, Officers, Directors, and members of select Board appointed committees and their related subcommittees, journal/periodical editors, and senior staff of the ADA must annually disclose any potential conflicts of interest. The American Diabetes Associations Audit and Governance Committee and senior staff in Legal Affairs manage the disclosure and monitoring processes. Through review of the annual disclosures and review of the agendas of the relevant Board, Committee and other meetings, appropriate efforts are made in advance of the meetings to identify potential conflicts of interest. Each person also has the responsibility to report his/her own conflicts of interest actual or perceived as those conflicts may arise during a meeting. Based on the situation, senior volunteers and staff presiding over the discussion are responsible to ensure appropriate action is taken for the individual to publicly disclose the conflict, for the individual to recuse him or herself from the discussion, vote or room as appropriate and to ensure the disclosure and action is documented in the minutes of the meeting. |
| Form 990, Part VI, Section B, Line 15a, 15b | Compensation Process Annually, The American Diabetes Association Principal Officers Chair of the Board President, Medicine Science President, Health Care Education and Secretary/Treasurer are responsible for establishing executive compensation consistent with the guidelines approved by the Compensation Committee. The Principal Officers of the ADA use a Compensation Committee, compensation studies and an independent consultant to establish the compensation of the Chief Executive Officer and other key employees. The Chief Executive Officer is responsible for the individual performance evaluations of staff officers and key employees, and establishes the total compensation for key employees subject to the guidelines established by the Executive Compensation Committee. The Executive Compensation Committee develops guidelines for the key employee executive positions listed below following the process described in the IRS intermediate sanctions rules when determining compensation. Specifically, the Committee 1 Is composed entirely of non-employee volunteer leaders who have no familial, business or significant personal relationships with the American Diabetes Association or its executives, 2 Assesses the short-term and long-term contribution and performance of CEO and other senior executive employees in meeting very definitive and quantifiable objectives focused on the ADAs mission success, 3 Engages an independent compensation consulting firm to compile appropriate comparability data including compensation market information for peers with whom the American Diabetes Association competes for executive talent, 4 The Committee reviews this data in detail for all elements of each executives total compensation, including but not limited to base salary, bonuses, perquisites, fringe benefits, and incentive and deferred compensation arrangements. Upon the executives hire, and at each point in time thereafter at which a new or revised compensation arrangement is under consideration with respect to the executive, the Committee meets before the arrangement is implemented to evaluate the reasonableness of the arrangement by comparing both the arrangement itself and the executives entire compensation package to compensation packages paid by similarly situated organizations for functionally comparable positions, 5 Documents, concurrently with its determination, the basis for its determination in the minutes of its meeting. These minutes are reviewed, revised if necessary and approved at the following meeting of the Executive Compensation Committee. The process described above was used to establish compensation for the following positions Chief Executive Officer, Chief Development and Delivery Officer, Chief Operating Officer, Chief Scientific and Medical Officer, Chief Advocacy Officer, Chief Strategy Officer, Vice President of Information Technology, Vice President of Human Resources, Chief Marketing and Digital Officer. The total compensation of executives at the American Diabetes Association is specifically designed to attract and retain the highest qualified executive talent to fulfill the critically important mission to prevent and cure diabetes and to improve the lives of all people affected by diabetes. |
| Form 990, Part VI, Section C, Line 17 | Filing Jurisdiction Registration Number Alabama-AL97-256, Alaska-N/A, Arizona-10145, Arkansas-N/A, California-CT81471, Colorado-2002-3003670, Connecticut-5084, District of Columbia-981855, Florida-CH1618, Georgia-CH-001422, Hawaii-N/A, Illinois-CO 01-025537, Indiana-000103829-000, Kansas- 177-257-3SO, Kentucky-45, Louisiana-N/A, Maine- CO-1247, Maryland-102, Massachusetts-029317, Michigan-MICS 10326, Minnesota-N/A, Mississippi- 100000294, Missouri- CO-021-87, New Hampshire-5006, New Jersey- CH-0581900, New Mexico-N/A, New York- 1/30/1965, North Carolina- SL000618, North Dakota-7894, Ohio- 01-0239, Oklahoma- N/A, Oregon- 16402, Pennsylvania- No. 21, Rhode Island-95-233, South Carolina-641, Tennessee-5104, Utah- 6536093-Char, Virginia-N/A, Washington-7664, West Virginia-N/A, Wisconsin- 3020-800. |
| Form 990, Part VI, Section C, Line 19 | The following information is available on the American Diabetes Associations website http//www.diabetes.org Board of Directors, Audited Consolidated Financial Statements, Latest 990 filed, Whistleblower policy. Available subject to request to the American Diabetes Association Legal Affairs department are the following Current Bylaws, Articles of Incorporation, Conflict of Interest Policy. |
| Form 990, Part VII, Section A, Line 1a1 | The Chief Executive Officer of the ADA is a non-voting member of the Board of Directors. |
| Form 990, Part IX, Line 11g | Other fees for services include the following Total Expenses / Program Service Expenses / Management and General Expenses / Fundraising ExpensesProgram execution fees 12,491,756 / 12,491,756 / 0 / 0Other fees for services 6,257,869 / 3,706,304 / 842,590 / 1,708,975 Total 18,749,625 / 16,198,060 / 842,590 / 1,708,975 |
| Form 990, Part VI, Section B, Line 12c | Research Grants Review Committee Conflict of Interest COI within the Research Grants Review Committee is managed through a written COI policy and through COI declarations signed both before and after the review cycle. The COI for grant reviewers is self reported. The primary considerations addressed in the COI policy and program guidelines are as follows Institutional Individuals are required to recuse themselves from reviewing grants for scientists at the same institution, including any institutions with which they may be negotiating employment. Financial Individuals are required to recuse themselves from reviewing grants from which they stand to gain financially if the grant is awarded co PI, collaborator, subcontracts, etc.. Personal Individuals are required to recuse themselves from reviewing grants for investigators with whom they either have a personal or professional relationship collaborators, colleagues or personal friends, or a long standing professional or scientific disagreement that prevents them from unbiased review. |
| Form 990, Part VII, Section A, Line 1-23 | Average hours per week is estimated based on meeting attendance and other ADA activities performed throughout the year. |
| Form 990, Part VI, Section A, Line 4 | In 2023, the maximum number of voting members of the Board of Directors was increased from 13 to 15. |
| Software ID: | 23017659 |
| Software Version: | 23.1.0.0 |